Saturday, 4 June 2022

Baby formula shortage could ease as Abbott reopens Michigan plant

Baby formula shortage could ease as Abbott reopens Michigan plant

Abbott Laboratories said on Saturday that it has reopened its baby formula production plant in Sturgis, Michigan, taking a step toward alleviating an acute nationwide shortage that has sent parents scrambling for supplies.

H&H working with FDA to up U.S. baby formula supplies

Health and Happiness (H&H) International Holdings Ltd is working closely with the U.S. Food and Drug Administration (FDA) to gain approval to send more infant formula supplies to the United States, a top executive said.

North Korea reports 79,100 more people with fever, one new death amid COVID wave

North Korea reported some 79,100 more people with fever symptoms and one additional death amid its first-confirmed coronavirus outbreak, state media KCNA said on Saturday.

Cancer research: Liquid biopsy identifies who can skip chemo after colon cancer surgery

The following are summaries of some of the cancer research advances being presented the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Gilead drug modestly delays breast cancer progression in late-stage trial

Gilead Sciences Inc's Trodelvy extended by 1.5 months, or 34%, the length of time women with advanced stages of the most common type of breast cancer lived without their disease worsening, according to late-stage trial data presented on Saturday.

India approves Biological E. COVID shot as a booster

India has approved Hyderabad-based drugmaker Biological E's COVID-19 vaccine as the first mix-and-match booster dose in the country, the company said on Saturday.

China reports 171 new COVID cases for June 3 vs 157 a day earlier

China recorded 171 new coronavirus cases on June 3, of which 46 were symptomatic and 125 were asymptomatic, the National Health Commission said on Saturday.

U.S. doctors urged to test for monkeypox, CDC says risk to public low

U.S. health officials on Friday urged doctors to test for monkeypox if they suspect cases, saying there may be community-level spread but that the overall public health risk remained low.

Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal

Bristol Myers Squibb Co said on Friday it will acquire drug developer Turning Point Therapeutics Inc for $4.1 billion in cash to help bolster its arsenal of cancer drugs.

U.S. doctors urged to test for monkeypox, CDC says risk to public low

U.S. health officials on Friday urged doctors to test for monkeypox if they suspect cases, saying there may be community-level spread but that the overall public health risk remained low.

Related Videos

Monkeypox "will not be like COVID" - Spanish microbiologist

Monkeypox can be contained if we act now: WHO

N.Korea reports more deaths amid COVID lockdown